DOI: 10.1055/s-00029028

Journal of Pediatric Infectious Diseases

LinksClose Window

References

Centers for Disease Control and Prevention (CDC); American Thoracic Society.
Update: adverse event data and revised American Thoracic Society/CDC recommendations against the use of rifampin and pyrazinamide for treatment of latent tuberculosis infection--United States, 2003.

MMWR Morb Mortal Wkly Rep 2003;
52 (31) 735-739

Download Bibliographical Data

Search in:

We do not assume any responsibility for the contents of the web pages of other providers.